Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gale

Showing results (621-630 of 9,151) with videos related to

Pageof 916
Sort By:
Diabetes Care|November 23, 2013
Response to comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125Edwin A M Gale
Diabetes|April 21, 2012
GLP-1-based therapies and the exocrine pancreas: more light, or just more heat?Edwin A M Gale
Medical Education|May 1, 1989
Changing medical educationJ Grant, R Gale
Brain Research|July 9, 1986
Role of excitatory amino acid transmission in the genesis of seizures elicited from the deep prepiriform cortexS Piredda, K Gale
Clinical Medicine (London, England)|January 2, 2004
Between two cultures: the expert clinician and the pharmaceutical industryEdwin A M Gale
Genetics|March 17, 2004
Effector genes of Xanthomonas axonopodis pv. vesicatoria promote transmission and enhance other fitness traits in the fieldGale Wichmann, Joy Bergelson
Mental Health Today (Brighton, England)|March 23, 2005
Even elders get the bluesLinda Seymour, Elizabeth Gale
European Journal of Pharmacology|December 10, 1991
Cocaine-induced turning behavior in rats with 6-hydroxydopamine lesions: effect of transplants of fetal substantia nigraR Meloni, K Gale
Immunity|January 29, 2013
Sterol-izing innate immunityCourtney Wilkins, Michael Gale
The New Zealand Medical Journal|March 7, 2013
Do all antidepressants cause QT prolongation--how good is the evidence?Paul Glue, Chris Gale
Pageof 916

Showing results (621-630 of 9,151) with videos related to

Sort By:
Pageof 916
Diabetes Care|November 23, 2013
Response to comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125Edwin A M Gale
Diabetes|April 21, 2012
GLP-1-based therapies and the exocrine pancreas: more light, or just more heat?Edwin A M Gale
Medical Education|May 1, 1989
Changing medical educationJ Grant, R Gale
Brain Research|July 9, 1986
Role of excitatory amino acid transmission in the genesis of seizures elicited from the deep prepiriform cortexS Piredda, K Gale
Clinical Medicine (London, England)|January 2, 2004
Between two cultures: the expert clinician and the pharmaceutical industryEdwin A M Gale
Genetics|March 17, 2004
Effector genes of Xanthomonas axonopodis pv. vesicatoria promote transmission and enhance other fitness traits in the fieldGale Wichmann, Joy Bergelson
Mental Health Today (Brighton, England)|March 23, 2005
Even elders get the bluesLinda Seymour, Elizabeth Gale
European Journal of Pharmacology|December 10, 1991
Cocaine-induced turning behavior in rats with 6-hydroxydopamine lesions: effect of transplants of fetal substantia nigraR Meloni, K Gale
Immunity|January 29, 2013
Sterol-izing innate immunityCourtney Wilkins, Michael Gale
The New Zealand Medical Journal|March 7, 2013
Do all antidepressants cause QT prolongation--how good is the evidence?Paul Glue, Chris Gale
Pageof 916